About stevanato group spa - STVN
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
STVN At a Glance
Stevanato Group SpA
Via Molinella 17
Piombino Dese, Padova 35017
| Phone | 39-49-9318111 | Revenue | 1.19B | |
| Industry | Medical Specialties | Net Income | 127.40M | |
| Sector | Health Technology | 2024 Sales Growth | 1.775% | |
| Fiscal Year-end | 12 / 2025 | Employees | N/A | |
| View SEC Filings |
STVN Valuation
| P/E Current | 34.171 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 46.372 |
| Price to Sales Ratio | 4.947 |
| Price to Book Ratio | 4.089 |
| Price to Cash Flow Ratio | 35.06 |
| Enterprise Value to EBITDA | 24.833 |
| Enterprise Value to Sales | 5.234 |
| Total Debt to Enterprise Value | 0.071 |
STVN Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 2.177 |
| Total Asset Turnover | 0.508 |
STVN Liquidity
| Current Ratio | 1.843 |
| Quick Ratio | 1.318 |
| Cash Ratio | 0.206 |
STVN Profitability
| Gross Margin | 26.455 |
| Operating Margin | 14.009 |
| Pretax Margin | 14.518 |
| Net Margin | 10.668 |
| Return on Assets | 5.421 |
| Return on Equity | 9.419 |
| Return on Total Capital | 6.711 |
| Return on Invested Capital | 7.684 |
STVN Capital Structure
| Total Debt to Total Equity | 30.546 |
| Total Debt to Total Capital | 23.399 |
| Total Debt to Total Assets | 18.42 |
| Long-Term Debt to Equity | 22.575 |
| Long-Term Debt to Total Capital | 17.293 |